Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein

Carcinogenesis

Volumn 31, Issue 8, 2010, Pages 1360-1366

  Fang, Wenfeng ^a,b   Goldberg, Marci L ^a   Pohl, Nicole M ^a   Bi, Xiuli ^a   Tong, Chang ^a   Xiong, Bin ^b   Koh, Timothy J ^a   Diamond, Alan M ^a   Yang, Wancai ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE 1; MESSENGER RNA; SELENIUM; SELENIUM BINDING PROTEIN; SELENIUM BINDING PROTEIN 1; SELENOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMAL FEED; ANIMALS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; COLORECTAL NEOPLASMS; DNA PRIMERS; GENE EXPRESSION REGULATION; GLUTATHIONE PEROXIDASE; HUMANS; INTESTINAL MUCOSA; KINETICS; MICE; MICE, INBRED C57BL; NEOPLASMS; PLASMIDS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SELENIUM; SELENIUM-BINDING PROTEINS; SELENOPROTEINS;

EID: 77955410455     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq114     Document Type: Article

References (45)

1. Behne, D. et al. (2001) Mammalian selenium-containing proteins. Annu. Rev. Nutr., 21, 453-473.
2. Kryukov, G.V. et al. (2003) Characterization of mammalian selenoproteomes. Science, 300, 1439-1443.
3. Hatfield, D.L. et al. (2002) How selenium has altered our understanding of the genetic code. Mol. Cell. Biol., 22, 3565-3576.
4. Wang, L. et al. (2009) Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev. Res. (Phila Pa), 2, 484-495.
5. Clark, L.C. et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276, 1957-1963.
6. Facompre, N. et al. (2009) Potential stages for prostate cancer prevention with selenium: implications for cancer survivors. Cancer Res., 69, 2699-2703.
7. Greenwald, P. et al. (2007) Clinical trials of vitamin and mineral supplements for cancer prevention. Am. J. Clin. Nutr., 85, 314S-317S.
8. Hawk, E.T. et al. (2005) Colorectal cancer prevention. J. Clin. Oncol., 23, 378-391.
9. Ip, C. (1998) Lessons from basic research in selenium and cancer prevention. J. Nutr., 128, 1845-1854.
10. Peters, U. et al. (2008) Selenium and the prevention of prostate and colorectal cancer. Mol. Nutr. Food Res., 52, 1261-1272.
11. Lippman, S.M. et al. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 301, 39-51.
12. Stranges, S. et al. (2007) Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann. Intern. Med., 147, 217-223.
13. Stranges, S. et al. Higher selenium status is associated with adverse blood lipid profile in British adults. J. Nutr., 140, 81-87.
14. Chang, P.W. et al. (1997) Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. J. Cell. Biochem., 64, 217-224.
15. Bansal, M.P. et al. (1989) Evidence for two selenium-binding proteins distinct from glutathione peroxidase in mouse liver. Carcinogenesis, 10, 541-546.
16. Bansal, M.P. et al. (1990) DNA sequencing of a mouse liver protein that binds selenium: implications for selenium's mechanism of action in cancer prevention. Carcinogenesis, 11, 2071-2073.
17. Chen, G. et al. (2004) Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J. Pathol., 202, 321-329.
18. Porat, A. et al. (2000) A 56-kDa selenium-binding protein participates in intra-Golgi protein transport. J. Biol. Chem., 275, 14457-14465.
19. Jeong, J.Y. et al. (2009) Human selenium binding protein-1 (hSP56) interacts with VDU1 in a selenium-dependent manner. Biochem. Biophys. Res. Commun., 379, 583-588.
20. Yang, M. et al. (1998) Differential expression and androgen regulation of the human selenium-binding protein gene hSP56 in prostate cancer cells. Cancer Res., 58, 3150-3153.
21. He, Q.Y. et al. (2004) Diverse proteomic alterations in gastric adenocarcinoma. Proteomics, 4, 3276-3287.
22. Huang, K.C. et al. (2006) Selenium binding protein 1 in ovarian cancer. Int. J. Cancer, 118, 2433-2440.
23. Kim, H. et al. (2006) Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics, 6, 3466-3476.
24. Li, T. et al. (2008) Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol. Nutr. Food Res., 52, 1289-1299.
25. Pohl, N.M. et al. (2009) Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts. PLoS ONE, 4, e7774.
26. Zhuo, P. et al. (2009) Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim. Biophys. Acta, 1790, 1546-1554.
27. Lei, X.G. et al. (2007) Metabolic regulation and function of glutathione peroxidase-1. Annu. Rev. Nutr., 27, 41-61.
28. Hu, Y.J. et al. (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res., 63, 3347-3351.
29. Hu, Y. et al. (2005) Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J. Nutr., 135, 3021S-3024S.
30. Baliga, M.S. et al. (2008) Selenoprotein deficiency enhances radiationinduced micronuclei formation. Mol. Nutr. Food Res., 52, 1300-1304.
31. Baliga, M.S. et al. (2007) Selenium and GPx-1 overexpression protect mammalian cells against UV-induced DNA damage. Biol. Trace Elem. Res., 115, 227-242.
32. Samuels, B.L. et al. (1991) Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. Cancer Res., 51, 521-527.
33. Novoselov, S.V. et al. (2005) Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. Oncogene, 24, 8003-8011.
34. Hu, D. et al. (2009) GSK3beta is involved in JNK2-mediated beta-catenin inhibition. PLoS One, 4, e6640.
35. Bellinger, F.P. et al. (2009) Regulation and function of selenoproteins in human disease. Biochem. J., 422, 11-22.
36. Fu, Y. et al. (2001) Opposite roles of selenium-dependent glutathione peroxidase-1 in superoxide generator diquatand peroxynitrite-induced apoptosis and signaling. J. Biol. Chem., 276, 43004-43009.
37. Gouaze, V. et al. (2002) Glutathione peroxidase-1 protects from CD95induced apoptosis. J. Biol. Chem., 277, 42867-42874.
38. Nasr, M.A. et al. (2004) GPx-1 modulates Akt and P70S6K phosphorylation and Gadd45 levels in MCF-7 cells. Free Radic. Biol. Med., 37, 187-195.
39. Brigelius-Flohe, R. et al. (2009) Glutathione peroxidases in different stages of carcinogenesis. Biochim. Biophys. Acta, 1790, 1555-1568.
40. Rushmore, T.H. et al. (1991) The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem., 266, 11632-11639.
41. Davis, C.D. et al. (2002) Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J. Nutr., 132, 307-309.
42. Gromadzinska, J. et al. (2008) Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements. Eur. J. Nutr., 47 (suppl. 2), 29-50.
43. Clark, L.C. et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA, 276, 1957-1963.
44. Duffield-Lillico, A.J. et al. (2003) Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int., 91, 608-612.
45. Lippman, S.M. et al. (2005) Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J. Natl Cancer Inst., 97, 94-102.